Crossref
SGLT2 Inhibition as a Novel "Metabolic Aquaretic" to Correct Thiazide-Induced Hyponatremia
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.202617ft0jda ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Negiin Pourafshar und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pourafshar, N., Madapoosi, S. S., Han, K., & Wilcox, C. S. (2026). SGLT2 Inhibition as a Novel "Metabolic Aquaretic" to Correct Thiazide-Induced Hyponatremia. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.202617ft0jda
Vancouver
Pourafshar N, Madapoosi SS, Han K, Wilcox CS. SGLT2 Inhibition as a Novel "Metabolic Aquaretic" to Correct Thiazide-Induced Hyponatremia. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.202617ft0jda
BibTeX
@article{Pourafshar2026,
author = {Pourafshar, Negiin and Madapoosi, Siddharth S. and Han, Karina and Wilcox, Christopher Stuart},
title = {SGLT2 Inhibition as a Novel "Metabolic Aquaretic" to Correct Thiazide-Induced Hyponatremia},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.202617ft0jda}
}
EUVIMED